| abstract |
Disclosed is a dry preparation of a room temperature stable vaccine comprising a live attenuated virus, a sugar stabilizer and an amino acid stabilizer. Live attenuated virus, 30% to 80% (w / w) non-reducing oligosaccharide, 5% to 40% (w / w) amino acid stabilizer, 2% to 20% (w / w) A dry formulation of a vaccine comprising a protein stabilizer of and a buffer having a pH of 6.0 to 8.0. [Selection figure] None |